European-focused life insurer Chesnara PLC (LSE:CSN) maintained its policy of raising dividends by 3% in its latest half-year, putting it on course for a 21st year of consecutive rises, something it says only seven companies across Europe can match.
Profit before tax for the six months to end June 2024 fell to £13.4 million (£15.3 million), with the value of policies in force (EcV) also down at £508 million (£524.7 million).
Itaconix PLC (AIM:ITX, OTCQB:ITXXF) told investors it remains on track to deliver full-year 2024 results in line with the board's expectations.
The company, in its interim results, for the six months ended 30 June, reported $2.8 million of revenue and $1.1 million of gross profit, as margin improved to 39% from 28%.
Futura Medical PLC (AIM:FUM, OTC:FAMDF) may have one eye on the upcoming US launch of its fast-acting erectile dysfunction gel Eroxon by healthcare giant Haleon.
However, its financial performance in the first half of 2024 was possibly more worthy of top billing as it booked a maiden £1 million profit on revenue of £7 million. It exited the period with £3.9 million on the balance sheet.
Empire Metals Ltd (AIM:EEE) has started its next major exploration programme at the Pitfield titanium project in Western Australia with drilling underway at its two main targets of Thomas and Cosgrove.
Around 1,000m of Diamond Core drilling will be completed in October, Empire said, to get a better geological understanding of the weathered cap zone, including thickness, grade and shape,
hVIVO PLC (AIM:HVO) reaffirmed revenue guidance for the year and said profit margins would be at the upper end of the range as it delivered a record first half.
It expects revenue to be £62 million for the 12 months and says £100 million is achievable by 2028.